IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1

被引:155
作者
Neufert, Clemens
Becker, Christoph
Wirtz, Stefan
Fantini, Massimo C.
Weigmann, Benno
Galle, Peter R.
Neurath, Markus F.
机构
[1] Univ Mainz, Med Clin 1, Immunol Lab, D-55101 Mainz, Germany
[2] Univ Roma Tor Vergata, I-00173 Rome, Italy
关键词
IL-27; STAT1; Th17; Treg;
D O I
10.1002/eji.200636896
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-27 is an IL-12-related cytokine frequently present at sites of inflammation that can promote both anti- and pro-inflammatory immune responses. Here, we have analyzed the mechanisms how IL-27 may drive such divergent immune responses. While IL-27 suppressed the development of proinflammatory Th17 cells, a novel role for this cytokine in inhibiting the development of anti-inflammatory, inducible regulatory T cells (iTreg) was identified. In fact, IL-27 suppressed the development of adaptive, TGF-beta-induced Forkhead box transcription factor p3-positive (Foxp3(+)) Treg. Whereas the blockade of Th17 development was dependent on the transcription factor STAT1, the suppression of iTreg development was STAT1. independent, suggesting that IL-27 utilizes different signaling pathways to shape T cell-driven immune responses. Our data thus demonstrate that IL-27 controls the development of Th17 and iTreg cells via differential effects on STAT1.
引用
收藏
页码:1809 / 1816
页数:8
相关论文
共 32 条
[1]   Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells [J].
Batten, Marcel ;
Li, Ji ;
Yi, Sothy ;
Kljavin, Noelyn M. ;
Danilenko, Dimitry M. ;
Lucas, Sophie ;
Lee, James ;
de Sauvage, Frederic J. ;
Ghilardi, Nico .
NATURE IMMUNOLOGY, 2006, 7 (09) :929-936
[2]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[3]   Development of Th1-type immune responses requires the type I cytokine receptor TCCR [J].
Chen, Q ;
Ghilardi, N ;
Wang, H ;
Baker, T ;
Xie, MH ;
Gurney, A ;
Grewal, IS ;
de Sauvage, FJ .
NATURE, 2000, 407 (6806) :916-920
[4]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[5]   Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling [J].
D'Cruz, LM ;
Klein, L .
NATURE IMMUNOLOGY, 2005, 6 (11) :1152-1159
[6]   Transforming growth factor β induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis [J].
Fantini, MC ;
Becker, C ;
Tubbe, I ;
Nikolaev, A ;
Lehr, HA ;
Galle, P ;
Neurath, MF .
GUT, 2006, 55 (05) :671-680
[7]   Cutting edge:: TGF-β induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 [J].
Fantini, MC ;
Becker, C ;
Monteleone, G ;
Pallone, F ;
Galle, PR ;
Neurath, MF .
JOURNAL OF IMMUNOLOGY, 2004, 172 (09) :5149-5153
[8]   A function for interleukin 2 in Foxp3-expressing regulatory T cells [J].
Fontenot, JD ;
Rasmussen, JP ;
Gavin, MA ;
Rudensky, AY .
NATURE IMMUNOLOGY, 2005, 6 (11) :1142-1151
[9]   Suppression of ongoing experimental autoimmune encephalomyelitis by neutralizing the function of the p28 subunit of IL-27 [J].
Goldberg, R ;
Zohar, Y ;
Wildbaum, G ;
Geron, Y ;
Maor, G ;
Karin, N .
JOURNAL OF IMMUNOLOGY, 2004, 173 (10) :6465-6471
[10]   The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis [J].
Hölscher, C ;
Hölscher, A ;
Rückerl, D ;
Yoshimoto, T ;
Yoshida, H ;
Mak, T ;
Saris, C ;
Ehlers, S .
JOURNAL OF IMMUNOLOGY, 2005, 174 (06) :3534-3544